title: Pure antiestrogens. The most important advance in the endocrine therapy of breast cancer since 1896.
authors.affiliation: Tenovus Cancer Research Center, University of Wales, College of Medicine, Cardiff, United Kingdom.
authors.forename: R I
authors.initials: RI
authors.lastname: Nicholson
authors.forename: J M
authors.initials: JM
authors.lastname: Gee
authors.forename: S
authors.initials: S
authors.lastname: Bryant
authors.forename: A B
authors.initials: AB
authors.lastname: Francis
authors.forename: R A
authors.initials: RA
authors.lastname: McClelland
authors.forename: J
authors.initials: J
authors.lastname: Knowlden
authors.forename: A E
authors.initials: AE
authors.lastname: Wakeling
authors.forename: C K
authors.initials: CK
authors.lastname: Osborne
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004965:Estrogen Antagonists / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*; D005260:Female; D006801:Humans
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists